Abuse of Opana ER (oxymorphone) associated with thrombotic thrombocytopenic purpura
3.5 out of 5 stars
Thrombotic Thrombocytopenic Purpura (TTP)-Like Illness Associated with Intravenous Opana ER Abuse — Tennessee, 2012. MMWR 2013 Jan 11;62:1-4.
Full Text
This paper describes a 2012 CDC investigation into a cluster of 15 cases of thrombotic thrombocytopenic purpura (TTP)-like illness in the state of Tennessee. TTP-like illness was defined as microangiopathic hemolytic anemia (hemolytic anemia anemia based on haptoglobin and lactate dehydrogenase with schistocytes and an admission platelet count < 50,000/μL. Typical TTP-like signs and symptoms included nausea (11 patients), abdominal pain (11), f...
Source: The Poison Review - January 15, 2013 Category: Toxicology Authors: Leon Tags: Medical opana oxymorphone thrombotic thrombocytopenic purpura ttp Source Type: news
Abuse of 'New' Opana Linked to Blood Disorder
(MedPage Today) -- Drug users who inject the new "abuse-deterrent" version of Opana ER (oxymorphone) may be at risk of developing a serious blood disease, according to Tennessee health officials. (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 12, 2013 Category: Urology & Nephrology Source Type: news
Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated with Intravenous Opana ER Abuse — Tennessee, 2012
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 11, 2013 Category: American Health Source Type: news
Blood Disorder Cases Tied to Prescription Painkiller Abuse
Addicts crushed, dissolved and injected Opana ER pills, CDC says
Source: HealthDay
Related MedlinePlus Pages: Pain Relievers, Platelet Disorders, Prescription Drug Abuse (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 10, 2013 Category: Consumer Health News Source Type: news
Abuse Resistance an Issue with Opioid Generics
(MedPage Today) -- As patents on popular opioid painkillers OxyContin (oxycodone) and Opana (oxymorphone) start expiring, makers of the brand products warn that the potential non-tamper-resistant generics are unsafe, and some legislators are concerned as well. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 4, 2013 Category: Psychiatry Source Type: news
Drug Makers Losing a Bid to Foil Generic Painkillers
The companies making the narcotic painkillers OxyContin and Opana have introduced tamper-resistant pills, hoping to slow adoption of the drugs’ generic versions. (Source: NYT Health)
Source: NYT Health - January 2, 2013 Category: Consumer Health News Authors: By KATIE THOMAS and BARRY MEIER Tags: Pain-Relieving Drugs Drugs (Pharmaceuticals) Drug Abuse and Traffic Food and Drug Administration OxyContin (Drug) Generic Brands and Products Source Type: news
